AT
HAE icon

American Trust’s Haemonetics HAE Stock Holding History

American Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,640
Closed -$208K – 459
2022
Q4 		$208K Sell
2,640
-728
-22% -$58.5K 0.02% 402
2022
Q3 		$249K Sell
3,368
-260
-7% -$18.7K 0.02% 330
2022
Q2 		$236K Sell
3,628
-42
-1% -$2.49K 0.02% 371
2022
Q1 		$232K Buy
+3,670
New +$200K 0.02% 421

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Trust's HAE Position: Q1 2023 in Review

American Trust sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 2,640 shares — an estimated $208K sold.

American Trust first reported a position in HAE in Q1 2022 and held it in 4 quarters. The position peaked at $249K in Q3 2022. 301 funds tracked by Wall St. Rank hold HAE as of Q1 2023.

  • American Trust reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
  • American Trust sold 2,640 Haemonetics shares in Q1 2023, an estimated $208K.
  • American Trust first reported a position in Haemonetics in Q1 2022 and held it in 4 quarters.
  • American Trust's Haemonetics position peaked at $249K in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.

Based on American Trust's 13F filing for Q1 2023, filed 22 May 2023.